 | • レポートコード：D0GIR-00634 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：New Technology |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、血漿由来療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。血漿由来療法の種類別市場規模（アルブミン、免疫グロブリン、VIII因子、その他）、用途別市場規模（血友病、一次免疫不全症（PID）、特発性血小板減少性紫斑病（ITP）、COVID-19、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：CSL Behring LLC、Bio Products Laboratory (BPL)、Kedrion、Shire、Octaparma、Bayer、Grifols、Biotest、Takeda、LFB ・地域別グローバル市場分析 2015年-2020年 ・血漿由来療法の北米市場（アメリカ、カナダ、メキシコ） ・血漿由来療法のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・血漿由来療法のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・血漿由来療法の南米市場（ブラジル、アルゼンチン） ・血漿由来療法の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アルブミン、免疫グロブリン、VIII因子、その他 ・用途別分析：血友病、一次免疫不全症（PID）、特発性血小板減少性紫斑病（ITP）、COVID-19、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Plasma-derived Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Plasma-derived Therapies sales will be xx in 2020 from Plasma-derived Therapies million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Plasma-derived Therapies market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Plasma-derived Therapies industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Plasma-derived Therapies and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Plasma-derived Therapies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Plasma-derived Therapies market has been segmented into:
Albumin
Immunoglobulin
Factor VIII
Others
By Application, Plasma-derived Therapies has been segmented into:
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Plasma-derived Therapies market presented in the report. This section sheds light on the sales growth of different regional and country-level Plasma-derived Therapies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Plasma-derived Therapies market.
The report offers in-depth assessment of the growth and other aspects of the Plasma-derived Therapies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Plasma-derived Therapies Market Share Analysis
Plasma-derived Therapies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Plasma-derived Therapies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Plasma-derived Therapies sales, revenue and market share for each player covered in this report.
The major players covered in Plasma-derived Therapies are:
CSL Behring LLC
Bio Products Laboratory (BPL)
Kedrion
Shire
Octaparma
Bayer
Grifols
Biotest
Takeda
LFB
Among other players domestic and global, Plasma-derived Therapies market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Plasma-derived Therapies Market Overview
1.1 Product Overview and Scope of Plasma-derived Therapies
1.2 Classification of Plasma-derived Therapies by Type
1.2.1 Global Plasma-derived Therapies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Plasma-derived Therapies Revenue Market Share by Type in 2019
1.2.3 Albumin
1.2.4 Immunoglobulin
1.2.5 Factor VIII
1.2.6 Others
1.3 Global Plasma-derived Therapies Market by Application
1.3.1 Overview: Global Plasma-derived Therapies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hemophilia
1.3.3 Primary Immunodeficiencies (PIDs)
1.3.4 Idiopathic Thrombocytopenic Purpura (ITP)
1.3.5 COVID-19
1.3.6 Others
1.4 Global Plasma-derived Therapies Market by Regions
1.4.1 Global Plasma-derived Therapies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Plasma-derived Therapies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Plasma-derived Therapies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Plasma-derived Therapies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Plasma-derived Therapies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Plasma-derived Therapies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Plasma-derived Therapies Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Plasma-derived Therapies Industry Impact
1.5.1 COVID-19 Potential Implications for the Plasma-derived Therapies
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Plasma-derived Therapies
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 CSL Behring LLC
2.1.1 CSL Behring LLC Details
2.1.2 CSL Behring LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 CSL Behring LLC SWOT Analysis
2.1.4 CSL Behring LLC Product and Services
2.1.5 CSL Behring LLC Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bio Products Laboratory (BPL)
2.2.1 Bio Products Laboratory (BPL) Details
2.2.2 Bio Products Laboratory (BPL) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bio Products Laboratory (BPL) SWOT Analysis
2.2.4 Bio Products Laboratory (BPL) Product and Services
2.2.5 Bio Products Laboratory (BPL) Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Kedrion
2.3.1 Kedrion Details
2.3.2 Kedrion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Kedrion SWOT Analysis
2.3.4 Kedrion Product and Services
2.3.5 Kedrion Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.4 Shire
2.4.1 Shire Details
2.4.2 Shire Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Shire SWOT Analysis
2.4.4 Shire Product and Services
2.4.5 Shire Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.5 Octaparma
2.5.1 Octaparma Details
2.5.2 Octaparma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Octaparma SWOT Analysis
2.5.4 Octaparma Product and Services
2.5.5 Octaparma Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer SWOT Analysis
2.6.4 Bayer Product and Services
2.6.5 Bayer Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.7 Grifols
2.7.1 Grifols Details
2.7.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Grifols SWOT Analysis
2.7.4 Grifols Product and Services
2.7.5 Grifols Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.8 Biotest
2.8.1 Biotest Details
2.8.2 Biotest Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Biotest SWOT Analysis
2.8.4 Biotest Product and Services
2.8.5 Biotest Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Takeda SWOT Analysis
2.9.4 Takeda Product and Services
2.9.5 Takeda Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.10 LFB
2.10.1 LFB Details
2.10.2 LFB Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 LFB SWOT Analysis
2.10.4 LFB Product and Services
2.10.5 LFB Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Plasma-derived Therapies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Plasma-derived Therapies Players Market Share
3.2.2 Top 10 Plasma-derived Therapies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Plasma-derived Therapies Revenue and Market Share by Regions
4.2 North America Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
4.3 Europe Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
4.5 South America Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
5 North America Plasma-derived Therapies Revenue by Countries
5.1 North America Plasma-derived Therapies Revenue by Countries (2015-2020)
5.2 USA Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
5.3 Canada Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
5.4 Mexico Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
6 Europe Plasma-derived Therapies Revenue by Countries
6.1 Europe Plasma-derived Therapies Revenue by Countries (2015-2020)
6.2 Germany Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
6.3 UK Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
6.4 France Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
6.5 Russia Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
6.6 Italy Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Plasma-derived Therapies Revenue by Countries
7.1 Asia-Pacific Plasma-derived Therapies Revenue by Countries (2015-2020)
7.2 China Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
7.3 Japan Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
7.4 Korea Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
7.5 India Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
8 South America Plasma-derived Therapies Revenue by Countries
8.1 South America Plasma-derived Therapies Revenue by Countries (2015-2020)
8.2 Brazil Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
8.3 Argentina Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Plasma-derived Therapies by Countries
9.1 Middle East & Africa Plasma-derived Therapies Revenue by Countries (2015-2020)
9.2 Saudi Arabia Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
9.3 UAE Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
9.4 Egypt Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
9.5 South Africa Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Plasma-derived Therapies Revenue and Market Share by Type (2015-2020)
10.2 Global Plasma-derived Therapies Market Forecast by Type (2019-2024)
10.3 Albumin Revenue Growth Rate (2015-2025)
10.4 Immunoglobulin Revenue Growth Rate (2015-2025)
10.5 Factor VIII Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Plasma-derived Therapies Market Segment by Application
11.1 Global Plasma-derived Therapies Revenue Market Share by Application (2015-2020)
11.2 Plasma-derived Therapies Market Forecast by Application (2019-2024)
11.3 Hemophilia Revenue Growth (2015-2020)
11.4 Primary Immunodeficiencies (PIDs) Revenue Growth (2015-2020)
11.5 Idiopathic Thrombocytopenic Purpura (ITP) Revenue Growth (2015-2020)
11.6 COVID-19 Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Plasma-derived Therapies Market Size Forecast (2021-2025)
12.1 Global Plasma-derived Therapies Market Size Forecast (2021-2025)
12.2 Global Plasma-derived Therapies Market Forecast by Regions (2021-2025)
12.3 North America Plasma-derived Therapies Revenue Market Forecast (2021-2025)
12.4 Europe Plasma-derived Therapies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Plasma-derived Therapies Revenue Market Forecast (2021-2025)
12.6 South America Plasma-derived Therapies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Plasma-derived Therapies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Plasma-derived Therapies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Plasma-derived Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Plasma-derived Therapies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Plasma-derived Therapies Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Plasma-derived Therapies Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. CSL Behring LLC Corporate Information, Location and Competitors
Table 7. CSL Behring LLC Plasma-derived Therapies Major Business
Table 8. CSL Behring LLC Plasma-derived Therapies Total Revenue (USD Million) (2017-2018)
Table 9. CSL Behring LLC SWOT Analysis
Table 10. CSL Behring LLC Plasma-derived Therapies Product and Solutions
Table 11. CSL Behring LLC Plasma-derived Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Bio Products Laboratory (BPL) Corporate Information, Location and Competitors
Table 13. Bio Products Laboratory (BPL) Plasma-derived Therapies Major Business
Table 14. Bio Products Laboratory (BPL) Plasma-derived Therapies Total Revenue (USD Million) (2018-2019)
Table 15. Bio Products Laboratory (BPL) SWOT Analysis
Table 16. Bio Products Laboratory (BPL) Plasma-derived Therapies Product and Solutions
Table 17. Bio Products Laboratory (BPL) Plasma-derived Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Kedrion Corporate Information, Location and Competitors
Table 19. Kedrion Plasma-derived Therapies Major Business
Table 20. Kedrion Plasma-derived Therapies Total Revenue (USD Million) (2017-2018)
Table 21. Kedrion SWOT Analysis
Table 22. Kedrion Plasma-derived Therapies Product and Solutions
Table 23. Kedrion Plasma-derived Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Shire Corporate Information, Location and Competitors
Table 25. Shire Plasma-derived Therapies Major Business
Table 26. Shire Plasma-derived Therapies Total Revenue (USD Million) (2017-2018)
Table 27. Shire SWOT Analysis
Table 28. Shire Plasma-derived Therapies Product and Solutions
Table 29. Shire Plasma-derived Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Octaparma Corporate Information, Location and Competitors
Table 31. Octaparma Plasma-derived Therapies Major Business
Table 32. Octaparma Plasma-derived Therapies Total Revenue (USD Million) (2017-2018)
Table 33. Octaparma SWOT Analysis
Table 34. Octaparma Plasma-derived Therapies Product and Solutions
Table 35. Octaparma Plasma-derived Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Bayer Corporate Information, Location and Competitors
Table 37. Bayer Plasma-derived Therapies Major Business
Table 38. Bayer Plasma-derived Therapies Total Revenue (USD Million) (2017-2018)
Table 39. Bayer SWOT Analysis
Table 40. Bayer Plasma-derived Therapies Product and Solutions
Table 41. Bayer Plasma-derived Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Grifols Corporate Information, Location and Competitors
Table 43. Grifols Plasma-derived Therapies Major Business
Table 44. Grifols Plasma-derived Therapies Total Revenue (USD Million) (2017-2018)
Table 45. Grifols SWOT Analysis
Table 46. Grifols Plasma-derived Therapies Product and Solutions
Table 47. Grifols Plasma-derived Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Biotest Corporate Information, Location and Competitors
Table 49. Biotest Plasma-derived Therapies Major Business
Table 50. Biotest Plasma-derived Therapies Total Revenue (USD Million) (2017-2018)
Table 51. Biotest SWOT Analysis
Table 52. Biotest Plasma-derived Therapies Product and Solutions
Table 53. Biotest Plasma-derived Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Takeda Corporate Information, Location and Competitors
Table 55. Takeda Plasma-derived Therapies Major Business
Table 56. Takeda Plasma-derived Therapies Total Revenue (USD Million) (2017-2018)
Table 57. Takeda SWOT Analysis
Table 58. Takeda Plasma-derived Therapies Product and Solutions
Table 59. Takeda Plasma-derived Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. LFB Corporate Information, Location and Competitors
Table 61. LFB Plasma-derived Therapies Major Business
Table 62. LFB Plasma-derived Therapies Total Revenue (USD Million) (2017-2018)
Table 63. LFB SWOT Analysis
Table 64. LFB Plasma-derived Therapies Product and Solutions
Table 65. LFB Plasma-derived Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Plasma-derived Therapies Revenue (Million USD) by Players (2015-2020)
Table 67. Global Plasma-derived Therapies Revenue Share by Players (2015-2020)
Table 68. Global Plasma-derived Therapies Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Plasma-derived Therapies Revenue Market Share by Regions (2015-2020)
Table 70. North America Plasma-derived Therapies Revenue by Countries (2015-2020)
Table 71. North America Plasma-derived Therapies Revenue Market Share by Countries (2015-2020)
Table 72. Europe Plasma-derived Therapies Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Plasma-derived Therapies Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Plasma-derived Therapies Revenue by Countries (2015-2020)
Table 75. South America Plasma-derived Therapies Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Plasma-derived Therapies Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Plasma-derived Therapies Revenue Market Share by Countries (2015-2020)
Table 78. Global Plasma-derived Therapies Revenue (Million USD) by Type (2015-2020)
Table 79. Global Plasma-derived Therapies Revenue Share by Type (2015-2020)
Table 80. Global Plasma-derived Therapies Revenue Forecast by Type (2021-2025)
Table 81. Global Plasma-derived Therapies Revenue by Application (2015-2020)
Table 82. Global Plasma-derived Therapies Revenue Share by Application (2015-2020)
Table 83. Global Plasma-derived Therapies Revenue Forecast by Application (2021-2025)
Table 84. Global Plasma-derived Therapies Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Plasma-derived Therapies Picture
Figure 2. Global Plasma-derived Therapies Revenue Market Share by Type in 2019
Figure 3. Albumin Picture
Figure 4. Immunoglobulin Picture
Figure 5. Factor VIII Picture
Figure 6. Others Picture
Figure 7. Plasma-derived Therapies Revenue Market Share by Application in 2019
Figure 8. Hemophilia Picture
Figure 9. Primary Immunodeficiencies (PIDs) Picture
Figure 10. Idiopathic Thrombocytopenic Purpura (ITP) Picture
Figure 11. COVID-19 Picture
Figure 12. Others Picture
Figure 13. Global Plasma-derived Therapies Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Plasma-derived Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Plasma-derived Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Plasma-derived Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Plasma-derived Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Plasma-derived Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Plasma-derived Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Plasma-derived Therapies Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Plasma-derived Therapies Revenue Market Share in 2019
Figure 22. Global Top 10 Players Plasma-derived Therapies Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Plasma-derived Therapies Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Plasma-derived Therapies Revenue Market Share by Regions (2015-2020)
Figure 26. Global Plasma-derived Therapies Revenue Market Share by Regions in 2018
Figure 27. North America Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 28. Europe Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 30. South America Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 32. North America Plasma-derived Therapies Revenue Market Share by Countries (2015-2020)
Figure 33. North America Plasma-derived Therapies Revenue Market Share by Countries in 2019
Figure 34. USA Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 35. Canada Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 37. Europe Plasma-derived Therapies Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Plasma-derived Therapies Revenue Market Share by Countries in 2019
Figure 39. Germany Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 40. UK Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 41. France Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 42. Russia Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 43. Italy Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Plasma-derived Therapies Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Plasma-derived Therapies Revenue Market Share by Countries in 2019
Figure 46. China Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 47. Japan Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 48. Korea Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 49. India Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 51. South America Plasma-derived Therapies Revenue Market Share by Countries (2015-2020)
Figure 52. South America Plasma-derived Therapies Revenue Market Share by Countries in 2019
Figure 53. Brazil Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Plasma-derived Therapies Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Plasma-derived Therapies Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 58. UAE Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Plasma-derived Therapies Revenue and Growth Rate (2015-2020)
Figure 61. Global Plasma-derived Therapies Revenue Share by Type (2015-2020)
Figure 62. Global Plasma-derived Therapies Revenue Share by Type in 2019
Figure 63. Global Plasma-derived Therapies Market Share Forecast by Type (2021-2025)
Figure 64. Global Albumin Revenue Growth Rate (2015-2020)
Figure 65. Global Immunoglobulin Revenue Growth Rate (2015-2020)
Figure 66. Global Factor VIII Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Plasma-derived Therapies Revenue Share by Application (2015-2020)
Figure 69. Global Plasma-derived Therapies Revenue Share by Application in 2019
Figure 70. Global Plasma-derived Therapies Market Share Forecast by Application (2021-2025)
Figure 71. Global Hemophilia Revenue Growth Rate (2015-2020)
Figure 72. Global Primary Immunodeficiencies (PIDs) Revenue Growth Rate (2015-2020)
Figure 73. Global Idiopathic Thrombocytopenic Purpura (ITP) Revenue Growth Rate (2015-2020)
Figure 74. Global COVID-19 Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Plasma-derived Therapies Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Plasma-derived Therapies Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Plasma-derived Therapies Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Plasma-derived Therapies Revenue Market Forecast (2021-2025)
Figure 80. Europe Plasma-derived Therapies Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Plasma-derived Therapies Revenue Market Forecast (2021-2025)
Figure 82. South America Plasma-derived Therapies Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Plasma-derived Therapies Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
オリゴヌクレオチドベース治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Oligonucleotide-based Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…- 再生医療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Regenerative Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Regenerative Therapies…
- 変形性関節症用再生医療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Regenerative Therapies for Osteoarthritis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Reg…
- 精密がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Precision Cancer Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Precision Cancer T…
- アンチエイジング療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Anti-Aging Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Aging Therapies mar…